Your Hair Loss May Not Be What Your Doctor Said It Was.

The androgen receptor is a protein on the surface of your hair follicles that binds testosterone and DHT. It’s the lock, and DHT is the key. When DHT binds to this receptor on your follicle cells, it triggers a cascade that shrinks the follicle (miniaturization) and shortens the growth phase of your hair cycle. This is the primary driver of male pattern baldness.

The AR gene has a variable section called a CAG repeat. The number of repeats determines how sensitive your androgen receptor is. Shorter repeats mean a more sensitive receptor; longer repeats mean a less sensitive one. People with shorter CAG repeats have more aggressive androgen-driven hair loss because their follicles respond more intensely to the same amount of DHT. This is why some men lose hair aggressively in their twenties while others maintain a full head of hair into their sixties despite similar testosterone levels.

If you have short CAG repeats, you likely experience noticeable hair loss even with normal DHT levels. Your follicles are simply more reactive. This is why DHT-blocking treatments (like finasteride) often work better for people with this variant. Your follicles are extremely responsive, so blocking the signal has a bigger effect.

5-alpha reductase type 2 is the enzyme that converts testosterone into DHT. This is the rate-limiting step in DHT production. More efficient SRD5A2, or certain variants that increase its activity, means more testosterone is being converted to DHT every day. Since DHT is the primary signal that shrinks hair follicles in androgenetic alopecia, this gene directly controls how much of that signal your follicles are receiving.

The V89L variant is one of the most studied. Approximately 30 to 40% of the population carries at least one copy of the variant allele, and people with two copies have higher DHT production from the same baseline testosterone. If you have the SRD5A2 variant, your body is converting testosterone to DHT more efficiently, which means more of the hormone that directly shrinks your follicles is being produced. This can accelerate hair loss even if your testosterone level is in a normal range.

You experience this as faster or more aggressive hair loss. Your follicles are being exposed to a higher concentration of the exact hormone that miniaturizes them. This is why finasteride specifically targets this enzyme. If you have high-converting SRD5A2 variants, blocking this conversion is one of the most effective interventions available.

Estrogen receptor alpha (ESR1) is a protein on hair follicles that binds estrogen and signals the follicle to stay in growth phase and resist DHT-driven miniaturization. Estrogen is protective; it actively counterbalances the shrinking signal from DHT. Without adequate estrogen signaling, hair follicles are left defenseless against DHT. This is why postmenopausal women often experience a sudden increase in hair loss even though their testosterone hasn’t changed. Their protective estrogen signaling has dropped.

The ESR1 gene has two common variants (PvuII and XbaI) that reduce how well the receptor binds estrogen. Approximately 40% of the population carries at least one variant allele. If you have ESR1 variants, your hair follicles are less responsive to the protective signal from estrogen, which means DHT has more power to miniaturize your follicles even when your estrogen levels are normal. You’re losing the backup protection.

You experience this as accelerated hair loss, especially around hormonal transitions (postpartum, perimenopause, or after stopping hormonal birth control). Your follicles aren’t getting the full protective benefit from estrogen, so they’re more vulnerable to the miniaturizing effect of DHT. Women with this variant often see improvement with estrogen-focused approaches (topical estrogen, estrogen-containing birth control, or HRT) in addition to DHT blockers.

MTHFR is the enzyme that converts folate into the active form your cells use for methylation, a biochemical process that’s essential for DNA synthesis, cellular division, and regeneration. Hair follicles are among the fastest-dividing cells in your body. They’re constantly generating new hair cells. If methylation is impaired, your follicles can’t regenerate efficiently. You get slow or impaired hair growth and accelerated shedding.

The C677T variant, carried by approximately 40% of the population, reduces MTHFR enzyme activity by 30 to 35%. If you have this variant, your cells are methylating at a reduced rate, which slows cellular turnover and regeneration in your hair follicles specifically. This doesn’t necessarily cause aggressive male pattern baldness, but it does cause diffuse thinning and slow regrowth because your follicles simply can’t divide and produce new hair as fast as they’re being shed.

You experience this as overall thinning rather than pattern loss, slow hair growth (your hair takes longer to get longer), and hair that feels finer or more fragile. Biotin supplements and basic hair care don’t help because the underlying problem is impaired methylation at the cellular level. Your follicles aren’t getting the methylation support they need to divide quickly enough to replace what’s being shed.

The vitamin D receptor (VDR) is a protein that binds activated vitamin D and signals your hair follicles to enter growth phase (anagen) and exit resting phase (telogen). Vitamin D is not just a nutrient. It’s a hormone that directly controls whether your follicles are actively growing or shedding. If VDR function is impaired, your follicles get stuck in resting or shedding phase and can’t be activated into growth phase even if vitamin D levels are adequate.

The VDR gene has several variants (BsmI and FokI are the most common). Approximately 30 to 50% of the population carries variants that reduce VDR receptor sensitivity or expression. If you have VDR variants, your hair follicles are less responsive to vitamin D signaling, which impairs their ability to enter and sustain growth phase, contributing to thinning and shedding. This is especially problematic in alopecia areata (autoimmune hair loss), but it also contributes to overall pattern thinning.

You experience this as persistent shedding, follicles that don’t seem to stay in growth phase, and slow regrowth even when you’re taking vitamin D supplements. Your follicles aren’t recognizing the vitamin D signal, so they’re not being activated. This is why some people with hair loss have low vitamin D levels, but correcting the deficiency alone doesn’t stop the hair loss. Their VDR variants mean their follicles need much higher vitamin D levels or more intensive signaling to respond.

The HFE gene regulates hepcidin, a hormone that controls iron absorption and storage. Iron is essential for the iron-sulfur clusters in the cytochrome enzymes that drive energy production in hair follicles. Without adequate iron, follicles don’t have the energy to sustain growth phase and shift into shedding. HFE variants can lead to either iron overload (if you carry hemochromatosis variants) or iron dysregulation that affects follicle cycling.

The most common HFE variants (C282Y and H63D) are carried by 10 to 15% of the population. If you have HFE variants, your iron regulation is impaired, and this affects the energy production and hormone signaling in your hair follicles, contributing to diffuse shedding or pattern thinning. This is often overlooked because standard iron panels don’t measure the specific iron status that follicles need.

You experience this as shedding that doesn’t respond to DHT blockers or minoxidil, persistent fatigue alongside hair loss (often dismissed as separate symptoms), and labs that show “normal” iron levels but symptoms that suggest deficiency. Your follicles are energy-starved. If you have HFE variants that increase iron absorption, excess iron can also accelerate hair loss by increasing oxidative stress in your follicles.